Request for Proposals: 2011 Advanced Clinical Research Award in Breast Cancer
The Conquer Cancer Foundation is working to create a world free from the fear of cancer by funding breakthrough research, by sharing knowledge with physicians and patients worldwide, and by supporting initiatives to ensure that all people have access to high-quality cancer care. Working in close collaboration with a global network of top scientists and clinicians, as well as leading advocacy and research organizations, the Foundation draws on the passion and expertise of the nearly 30,000 oncology professionals who are members of its affiliate organization, the American Society of Clinical Oncology (ASCO.) For more information, visit www.conquercancerfoundation.org .
The Breast Cancer Research Foundation is an independent 501 (c) (3) not-for-profit organization whose mission is to achieve prevention and a cure for breast cancer in our lifetime by providing critical funding for innovative clinical and translational research at leading medical centers worldwide, and increasing public awareness about good breast health.
The Advanced Clinical Research Award (ACRA) is designed to fund mid-career investigators who are committed to clinical cancer research and who wish to conduct original research not currently funded.
Funding Available
The grant is funded at the level of $450,000, paid in three (3) annual increments of $150,000 per year on October 1. The grant includes $137,000 per year to support the research project, $2,500 per year for travel related to the project (including the ASCO Annual Meeting), and $10,500 per year (or 7% of the yearly total award amount) for overhead or indirect costs. Grant funds may not be applied to patient care costs that are reimbursable by a third party payor.
Eligibility Criteria
The Advanced Clinical Research Award in Breast Cancer is intended to support proposals with a patient-oriented focus, including a clinical research study and/or translational research involving human subjects. ASCO's definition of clinical research is "hypothesis-driven research that employs measurements in whole patients or normal human subjects, in conjunction with laboratory measurements as appropriate; on the subjects of clinical biology, natural history, prevention, screening, diagnosis, therapy, or the epidemiology of neoplastic disease" (Journal of Clinical Oncology, Vol. 14, No. 2, 1996, pp. 666-670). Proposals with a predominant focus on in vitro or animal studies (even if clinically relevant) are not allowed.
Applicantsmust meet the following criteria:
• Be a physician (MD, DO, or international equivalent) who is in the fourth to ninth year of a full-time, primary faculty appointment in a clinical department at an academic medical institution at the time of grant submission.
• Have completed productive post doctoral/post fellowship research and demonstrated the ability to undertake independent investigator-initiated clinical research.
• Be an active member of ASCO or have submitted a membership application with the grant application.
• Be able to commit 75% of full-time effort in research (applies to total research, not just the proposed project) during the award period.
The Conquer Cancer Foundation reserves the right to evaluate and determine applicants' eligibility based on the information and justifications included in the application materials.
Letter of Intent Due: May 3, 2011 by 11:59 pm EDT
Full Application Due: June 14, 2011 by 11:59 pm EST
Award Notification Date: September 1, 2011
Award Term: October 1, 2011 – September 30, 2014
Applicants are encouraged to start their application early due to the complexity of the online application process.
To initiate an application, please go to https://grants.conquercancerfoundation.org.
Conquer Cancer Foundation
2318 Mill Road, Suite 800
Alexandria, VA. 22314
571-483-1700
info@conquercancerfoundation.org
